درباره این اپیزود
Pharma doesn't necessarily need more content. It needs content that teams can find, reuse, adapt, and deliver when it's needed.
In Part 1 of this Pharma Talks conversation, Nataliya Andreycuk sits down with Rasmus Kalms, technologist and product leader, to challenge the way pharma approaches content production, modular content, and AI.
Why do content management practices that work in other industries often look different in pharma? Can generative AI solve the problem of fragmented content libraries? And is modular content really dead — or have we simply made it too complicated?
Rasmus shares his perspective on why a solid claims library, structured content, and transparent workflows are essential to making AI work in regulated environments. Together, Nataliya and Rasmus explore how pharma can rethink content operations, accelerate production, and build workflows that support both compliance and creativity.
00:00 Does pharma have a content graveyard problem?
04:03 Why pharma's approach to content may be part of the problem
08:55 From digital asset management to meaningful content reuse
14:41 Making modular content scalable with AI
16:08 Is compliance a constraint or an excuse for inaction?
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Rasmus Kalms → https://www.linkedin.com/in/kalms/
